Nurix earns $10M milestone as Sanofi starts STAT6 degrader trial

August 4, 2026 7:00 AM

Nurix Therapeutics (Nasdaq: NRIX) announced it has earned a $10 million milestone payment after its collaborator Sanofi initiated a Phase ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found